NATROX® O₂ for Diabetic Foot Ulcers

About Inotec AMD

Inotec AMD is a commercial-stage medical device company addressing the significant global burden of chronic wounds through its innovative NATROX® O₂ topical oxygen delivery system. The device has garnered strong clinical support, including high-level guideline recommendations from international bodies like the IWGDF and ADA for diabetic foot ulcers. With a growing evidence base, key distributor partnerships, and availability through major channels like the NHS Supply Chain, the company is positioned to capture share in the large and costly chronic wound care market.

Therapeutic Areas